- Home
- RSLS vs NAOV Comparison
RSLS vs NAOV Comparison
Compare RSLS & NAOV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RSLS
- NAOV
- Stock Information
- Founded
- RSLS 2002
- NAOV 2003
- Country
- RSLS United States
- NAOV United States
- Employees
- RSLS N/A
- NAOV N/A
- Industry
- RSLS Medical/Dental Instruments
- NAOV Industrial Specialties
- Sector
- RSLS Health Care
- NAOV Health Care
- Exchange
- RSLS Nasdaq
- NAOV Nasdaq
- Market Cap
- RSLS 3.2M
- NAOV 2.8M
- IPO Year
- RSLS 2007
- NAOV N/A
- Fundamental
- Price
- RSLS $0.64
- NAOV $2.21
- Analyst Decision
- RSLS Hold
- NAOV
- Analyst Count
- RSLS 1
- NAOV 0
- Target Price
- RSLS N/A
- NAOV N/A
- AVG Volume (30 Days)
- RSLS 3.3M
- NAOV 1.1M
- Earning Date
- RSLS 05-14-2025
- NAOV 04-07-2025
- Dividend Yield
- RSLS N/A
- NAOV N/A
- EPS Growth
- RSLS N/A
- NAOV N/A
- EPS
- RSLS N/A
- NAOV N/A
- Revenue
- RSLS $8,183,000.00
- NAOV $3,291,000.00
- Revenue This Year
- RSLS $17.47
- NAOV N/A
- Revenue Next Year
- RSLS $20.00
- NAOV N/A
- P/E Ratio
- RSLS N/A
- NAOV N/A
- Revenue Growth
- RSLS N/A
- NAOV 227.79
- 52 Week Low
- RSLS $0.61
- NAOV $1.92
- 52 Week High
- RSLS $29.00
- NAOV $13.97
- Technical
- Relative Strength Index (RSI)
- RSLS 19.62
- NAOV 27.08
- Support Level
- RSLS $0.63
- NAOV $3.36
- Resistance Level
- RSLS $1.28
- NAOV $4.19
- Average True Range (ATR)
- RSLS 0.12
- NAOV 0.46
- MACD
- RSLS 0.06
- NAOV -0.10
- Stochastic Oscillator
- RSLS 3.31
- NAOV 12.57
About RSLS ReShape Lifesciences Inc.
Reshape Lifesciences Inc is a medical device company focused on technologies to treat obesity and metabolic diseases. The company's current portfolio includes the LAP-BAND, an Adjustable Gastric Banding System, ReShapeCare virtual health coaching program, ReShape Market Place, including ReShape Optimize a supplemental multivitamin, the Obalon Balloon System, the first and only swallowable gas-filled balloon system, and the Diabetes Bloc-Stim Neuromodulation, a technology under development as a new treatment for type 2 diabetes mellitus.
About NAOV NanoVibronix Inc.
NanoVibronix Inc manufactures noninvasive biological response-activating devices that target biofilm prevention, pain therapy, and wound healing and can be administered at home, without the assistance of medical professionals. Its primary products are UroShield; PainShield; and WoundShield. Each of its UroShield, PainShield, and WoundShield products employs a small, disposable transducer that transmits low-frequency, low-intensity ultrasound acoustic waves that seek to repair and regenerate tissue, musculoskeletal and vascular structures, and decrease biofilm formation on urinary catheters and associated urinary tract infections. The company derives revenues from selling its products directly to patients as well as through distributor agreements.